These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11419611)

  • 1. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study.
    Keefer L; Blanchard EB
    Behav Res Ther; 2001 Jul; 39(7):801-11. PubMed ID: 11419611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome.
    Keefer L; Blanchard EB
    Behav Res Ther; 2002 May; 40(5):541-6. PubMed ID: 12038646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of irritable bowel syndrome with hypnotherapy.
    Galovski TE; Blanchard EB
    Appl Psychophysiol Biofeedback; 1998 Dec; 23(4):219-32. PubMed ID: 10457813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation training as a treatment for irritable bowel syndrome.
    Blanchard EB; Greene B; Scharff L; Schwarz-McMorris SP
    Biofeedback Self Regul; 1993 Sep; 18(3):125-32. PubMed ID: 8218507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behaviorally treated irritable bowel syndrome patients: a four-year follow-up.
    Schwarz SP; Taylor AE; Scharff L; Blanchard EB
    Behav Res Ther; 1990; 28(4):331-5. PubMed ID: 2222390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral treatment of irritable bowel syndrome: a 1-year follow-up study.
    Schwarz SP; Blanchard EB; Neff DF
    Biofeedback Self Regul; 1986 Sep; 11(3):189-98. PubMed ID: 3300787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome.
    Blanchard EB; Schwarz SP; Suls JM; Gerardi MA; Scharff L; Greene B; Taylor AE; Berreman C; Malamood HS
    Behav Res Ther; 1992 Mar; 30(2):175-89. PubMed ID: 1567347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment outcome measures for irritable bowel syndrome.
    Meissner JS; Blanchard EB; Malamood HS
    Appl Psychophysiol Biofeedback; 1997 Mar; 22(1):55-62. PubMed ID: 9287255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
    Camilleri M; Chey WY; Mayer EA; Northcutt AR; Heath A; Dukes GE; McSorley D; Mangel AM
    Arch Intern Med; 2001 Jul; 161(14):1733-40. PubMed ID: 11485506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive therapy for patients with refractory irritable bowel syndrome].
    Wang W; Pan G; Qian J
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):156-9. PubMed ID: 11940313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive therapy for irritable bowel syndrome.
    Greene B; Blanchard EB
    J Consult Clin Psychol; 1994 Jun; 62(3):576-82. PubMed ID: 8063984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome.
    Payne A; Blanchard EB
    J Consult Clin Psychol; 1995 Oct; 63(5):779-86. PubMed ID: 7593870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.
    Heymann-Mönnikes I; Arnold R; Florin I; Herda C; Melfsen S; Mönnikes H
    Am J Gastroenterol; 2000 Apr; 95(4):981-94. PubMed ID: 10763948
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
    World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms.
    Colwell LJ; Prather CM; Phillips SF; Zinsmeister AR
    Am J Gastroenterol; 1998 Jun; 93(6):901-5. PubMed ID: 9647015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.